Riskpilot← Back to searchSign inGet full accessKyowa Kirin AB
ABActiveOrg 5566623038Torshamnsgatan 39 6trWholesale of pharmaceutical and medical goods · NACE 4646Est. 20045-9 employees
Revenue 2024
SEK 80,4M
-49% vs 2023
EBITDA margin
3.2%
-72% vs 2023
Equity ratio
33.4%
Financial strength
Net profit 2024
SEK -429K
-106% vs 2023
| Revenue | SEK 80,4M | -49% |
| EBITDA | SEK 2,5M | -72% |
| Net profit | SEK -429K | -106% |
| Total assets | SEK 68,2M | -32% |
| Equity | SEK 22,7M | -44% |
| Employees | — | — |
Legal name
Kyowa Kirin AB
Org number
5566623038
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14 maj 2004
Share capital
SEK 200 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall marknadsföra och sälja läkemedel och bedriva därtill hörande verksamhet.
Address
Torshamnsgatan 39 6tr
Email
john.strandberg@kyowakirin.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 139 242 | 184 910 | 202 081 | 157 453 | 80 356 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 642 | 7 516 | 8 531 | 9 106 | 2 543 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 6 642 | 7 516 | 8 531 | 9 106 | 2 543 |
| Net financials | −39 | −92 | −200 | 7 | −7 |
| Profit before tax | 6 603 | 7 424 | 8 332 | 9 113 | 2 536 |
| Tax | −2 265 | −1 699 | −1 969 | −2 060 | −2 965 |
| Net profit | 4 338 | 5 725 | 6 363 | 7 053 | −429 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 88 010 | 132 125 | 140 303 | 100 641 | 68 160 |
| Equity | 21 782 | 27 506 | 33 770 | 40 977 | 22 748 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 66 228 | 104 619 | 106 532 | 59 663 | 45 412 |
| Total debt | 66 228 | 104 619 | 106 532 | 59 663 | 45 412 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
33.4%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
-1.9%
This company
18.4%
Market median
-110% vs market
20202024
Net profit margin
-0.5%
This company
8.1%
Market median
-106% vs market
20202024
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
20202024
Debt / equity
2.00×
This company
0.62×
Market median
-223% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PG Chief Auditor | Chief Auditor | 2020 |
JS Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (3) | ||
GA Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
CB Chief Executive Officer | Chief Executive Officer | 2020 – 2020 |
JH Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Former (6) | ||
| Board of Directors | 2020 – 2024 | |
| Chairman | 2020 – 2020 | |
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2020 – 2020 | |
| Chairman | 2023 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kyowa Kirin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Gustaf Hammar | Chief Auditor | 0 companies |
| Gary Adamson | Chief Executive Officer | 0 companies |
| Camilla Birgitta Jansdotter Oldgren | Chief Executive Officer | 0 companies |
| Johan Henrik Hübner | Authorized Recipient of Service | 0 companies |
| John Strandberg | Chief Executive Officer | 0 companies |
| Emmanuéle Claude S Claeys | Board of Directors | 0 companies |
| Andrew McLean | Chairman | 0 companies |
| Angelika Plamenova Sedlackova | Board of Directors | 0 companies |
| Richard James Johnson | Board of Directors | 0 companies |
| Allan Mark Watson | Board of Directors | 0 companies |
| Richard Gerardus Franciscus van den Dungen | Board of Directors | 0 companies |
| Daniel James Atterbury Davies | Board of Directors | 0 companies |
| Roswitha Reisinger | Chairman | 0 companies |